As Research Into Pain Accelerates, A Newly Recognized Type Of Pain Comes To The Forefront - Tonix Targets It With FDA-Fast Track-Designated TNX-102 SL - Tonix Pharmaceuticals ( NASDAQ:TNXP )

2 weeks ago

Research into the causes and nature of pain is accelerating and broadening, as evidenced by the more than 400 scientific presentations at the 2024 World Congress on Pain, held August 6-9 in Amsterdam, which was sponsored by the International Association for the Study of Pain

Ticker	Sentiment	Impact
TNXP	Neutral	11 %